Guggenheim lowered the firm’s price target on Itron (ITRI) to $133 from $135 and keeps a Buy rating on the shares. Following a post-earnings catchup with management, the firm made some “small tweaks to our model,” notes the analyst, who continues to identify Itron as a “Best Idea.”
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITRI: